©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Nov 14, 2006; 12(42): 6861-6864
Published online Nov 14, 2006. doi: 10.3748/wjg.v12.i42.6861
Published online Nov 14, 2006. doi: 10.3748/wjg.v12.i42.6861
Table 1 HCV-RNA clearance at different time points in 2 groups after treatment n (%)
| Group A | Group B | P | |
| (n = 22) | (n = 23) | ||
| At 26 wk (EVR) | 7 (31.8) | 8 (34.8) | NS |
| At 52 wk (ETR) | 7 (31.8) | 8 (34.8) | NS |
| At 76 wk (SVR) | 6 (27.3) | 6 (26.1) | NS |
Table 2 ALT normalization at different time points in 2 groups after treatment n (%)
| Group A | Group B | P | |
| (n = 22) | (n = 23) | ||
| At 4 wk | 12 (54.5) | 10 (43.5) | NS |
| At 12 wk | 13 (59.1) | 13 (56.5) | NS |
| At 26 wk (EVR) | 13 (59.1) | 13 (56.5) | NS |
| At 52 wk (ETR) | 12 (54.5) | 10 (43.5) | NS |
| At 76 wk (SVR) | 6 (27.3) | 6 (26.2) | NS |
- Citation: Alaimo G, Marco VD, Ferraro D, Stefano RD, Porrovecchio S, D’Angelo F, Calvaruso V, Craxì A, Almasio PL. Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: A randomized controlled trial. World J Gastroenterol 2006; 12(42): 6861-6864
- URL: https://www.wjgnet.com/1007-9327/full/v12/i42/6861.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i42.6861